Cell
Volume 54, Issue 1, 1 July 1988, Pages 65-72
Journal home page for Cell

Article
Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4

https://doi.org/10.1016/0092-8674(88)90180-8Get rights and content

Abstract

Saturation mutagenesis and a complement fixation selection have yielded CD4 point mutants with impaired antibody and human immunodeficiency virus binding. The patterns of amino acid substitution, in conjunction with previous antibody cross-blocking data, affirm the similar tertiary structures of the CD4 amino-terminal domain and immunoglobulin variable regions. Single residue substitutions affecting virus binding and syncytium formation are observed over an eight residue segment located in a portion of the molecule homologous to the second hypervariable region of an antibody combining site.

References (33)

  • S. Chakrabarti et al.

    Expression of the HTLV-III envelope gene by a recombinant vaccinia virus

    Nature

    (1986)
  • T.C. Chanh et al.

    Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus

  • A.G. Dalgleish et al.

    The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus

    Nature

    (1984)
  • A.G. Dalgleish et al.

    Neutralisation of HIV isolates by anti-idiotypic antibodies which mimic the T4(CD4) epitope: a potential AIDS vaccine

    Lancet

    (1987)
  • W. Furey et al.

    Structure of a novel Bence-Jones protein (RHE) fragment at 1.6 angstrom resolution

    J. Mol. Biol.

    (1983)
  • V. Horejsi et al.

    Reactivity of the workshop CD4 and CD6 panel antibodies with the respective purified antigens

  • Cited by (283)

    • Reduced monomeric CD4 is the preferred receptor for HIV

      2010, Journal of Biological Chemistry
      Citation Excerpt :

      The nature of this conformational change is unknown, although residues located in domain 2 have been implicated in the change. Domain 2 residues Pro121, Pro122, Gly123 (32), and Asn164 (33) were found to be important for a high affinity CD4-gp120 interaction, and antibodies that bind to epitopes that encompass these residues block HIV syncitia formation and/or infection (29, 33–37). These residues are also within two stretches of domain 2 amino acids, 120–127 or 163–166, that from molecular modeling studies have been proposed to constitute a hinge that bends upon HIV binding to domain 1 (12).

    • Molecular and functional analysis of the antigen receptor of Art v 1-specific helper T lymphocytes

      2008, Journal of Allergy and Clinical Immunology
      Citation Excerpt :

      Conventionally, altered peptide ligands are created by introducing single amino acid changes into peptide ligands of MHC, generating peptides able to influence autoimmune diseases but also allergies.39-42 The Ii-based allergen (peptide) expression system in combination with, for example, error-prone PCR approaches,43 might serve as a novel high-throughput screening approach for such purposes. Moreover, expressible allergen-specific TCRs might also lay the groundwork for the generation of valuable in vivo systems in the future, such as TCR tg “allergy mice” based on a human disease and based on human immune receptors.

    • Critical role of Arg<sup>59</sup> in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection

      2007, Virology
      Citation Excerpt :

      Based on crystal structure analyses, phenylalanine at position 43 (Phe43) and arginine at position 59 (Arg59) within the high-affinity gp120-binding region of CD4 are predicted to make multiple contacts centered on Asp368, Glu370, and Trp427 of the C3 and C4 regions of gp120 (Kwong et al., 1998, 2000). Specifically, it has been shown that Asp368 of gp120 forms a salt bridge with Arg59 of the CD4 receptor (Brodsky et al., 1990; Peterson and Seed, 1988; Wyatt and Sodroski, 1998), and that the viral gp120 and cellular CD4 molecule form hydrogen bonds, which bridge the two proteins (Wyatt and Sodroski, 1998). These interactions are believed to trigger conformational changes in the viral gp120 (Sattentau and Moore, 1991) that facilitate binding of the gp120/CD4 complex to the cellular co-receptor (Deng et al., 1996; Salzwedel et al., 2000; Trkola et al., 1996; Wu et al., 1996).

    • LFA-1 and associated diseases: The dark side of a receptor

      2006, Clinical and Applied Immunology Reviews
      Citation Excerpt :

      Furthermore, it is of considerable interest that viruses have evolved to bind to the same regions of CD4 and ICAM-1 as do their cell adhesion counter-structures. Indeed, HIV binds to the first and part of the second immunoglobulin-like domains of CD4 [75,94–96], the region that binds to major histocompatibility complex class II molecules [95]. In the same way, LFA-1 and rhinoviruses bind to overlapping but distinct regions of the first immunoglobulin-like domain of ICAM-1 [97–100].

    View all citing articles on Scopus
    View full text